Current Drug Targets. Inflammation & Allergy,volume 3,issue 3  (01-2004)

Period of time： 2004年3期

Publisher： Bentham Science Publishers

Founded in： 2002

Total resources： 14

E-ISSN： 1875-5933|3|3

ISSN： 1568-010X

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Current Drug Targets. Inflammation & Allergy,volume 3,issue 3

Menu

Preface [Hot Topic: Novel and Alternative Non-Steroidal Treatments for Asthmatic Inflammation (Guest Editor: Mario Cazzola)]

Current Drug Targets. Inflammation & Allergy,volume 3,issue 3 , Vol. 3, Iss. 3, 2004-09 , pp. i-ii

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Glycosaminoglycans and the Regulation of Allergic Inflammation

Current Drug Targets. Inflammation & Allergy,volume 3,issue 3 , Vol. 3, Iss. 3, 2004-09 , pp. 221-225

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Anti-IgE Monoclonal Antibody (Omalizumab) in the Treatment of Atopic Asthma and Allergic Respiratory Diseases

Current Drug Targets. Inflammation & Allergy,volume 3,issue 3 , Vol. 3, Iss. 3, 2004-09 , pp. 227-229

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The Potential of PDE4 Inhibitors in Respiratory Disease

Current Drug Targets. Inflammation & Allergy,volume 3,issue 3 , Vol. 3, Iss. 3, 2004-09 , pp. 231-236

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Potential Role of Antibiotics in the Treatment of Asthma

Current Drug Targets. Inflammation & Allergy,volume 3,issue 3 , Vol. 3, Iss. 3, 2004-09 , pp. 237-242

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Targeting Th2 Cells in Asthmatic Airways

Current Drug Targets. Inflammation & Allergy,volume 3,issue 3 , Vol. 3, Iss. 3, 2004-09 , pp. 243-255

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Chemokine Receptor Inhibitors as a Novel Option in Treatment of Asthma

Current Drug Targets. Inflammation & Allergy,volume 3,issue 3 , Vol. 3, Iss. 3, 2004-09 , pp. 257-261

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Cytokine-Directed Therapy in Asthma

Current Drug Targets. Inflammation & Allergy,volume 3,issue 3 , Vol. 3, Iss. 3, 2004-09 , pp. 263-269

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Anti-Inflammatory Activities of 2-Agonists

Current Drug Targets. Inflammation & Allergy,volume 3,issue 3 , Vol. 3, Iss. 3, 2004-09 , pp. 271-277

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis

Current Drug Targets. Inflammation & Allergy,volume 3,issue 3 , Vol. 3, Iss. 3, 2004-01 , pp. 279-290

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 16 item(s)